KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial

Samankaltaisia teoksia

• Histopathological Downstaging of Colon Cancer Following Six Weeks of Pre-operative Chemotherapy: Early Results of the NCRI FOxTROT Trial
  Tekijä: West, N, et al.
  Julkaistu: (2012)
• FOxTROT: Randomized phase II study of neoadjuvant chemotherapy with or without an anti-EGFR monoclonal antibody for locally advanced, operable colon cancer
  Tekijä: Gray, R, et al.
  Julkaistu: (2010)
• FOxTROT: Randomized phase II study of neoadjuvant chemotherapy (CT) with or without an anti-EGFR monoclonal antibody for locally advanced, operable colon cancer: Planned interim report
  Tekijä: Morton, D, et al.
  Julkaistu: (2011)
• Intra-tumoral Heterogeneity of KRAS and BRAF Mutation Status in Patients with Advanced Colorectal Cancer (aCRC) and Cost-Effectiveness of Multiple Sample Testing
  Tekijä: Susan D. Richman, et al.
  Julkaistu: (2011-01-01)
• Whiskey Tango Foxtrot: Technological Convergence?
  Tekijä: Anne-Laure Mention, et al.
  Julkaistu: (2018-11-01)